0000914475-24-000154.txt : 20240523
0000914475-24-000154.hdr.sgml : 20240523
20240523183403
ACCESSION NUMBER: 0000914475-24-000154
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sharp Shalini
CENTRAL INDEX KEY: 0001377202
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 24980228
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330525145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6027 EDGEWOOD BEND COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
wk-form4_1716503634.xml
FORM 4
X0508
4
2024-05-22
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001377202
Sharp Shalini
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
1
0
0
0
0
Restricted Stock Unit
0
2024-05-22
4
A
0
1435
0
A
Common Stock
1435
1435
D
Non-Qualified Stock Option
139.43
2024-05-22
4
A
0
2982
0
A
2034-05-22
Common Stock
2982
2982
D
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
The RSUs will vest in full on May 22, 2025.
Option vests in 12 monthly installments beginning June 22, 2024.
/s/ Darin Lippoldt, Attorney-in-Fact
2024-05-23